Dr. Adamstein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
75 Francis St.
Boston, MA 02115Phone+1 617-732-5500- Is this information wrong?
Education & Training
- Brigham and Women's HospitalFellowship, Cardiovascular Disease, 2023 - 2027
- Brigham and Women's HospitalResidency, Internal Medicine, 2020 - 2023
- Columbia University Vagelos College of Physicians and SurgeonsClass of 2020, MD
- Washington University in St. LouisBA, Chemistry, Philosophy, 2011 - 2015
Certifications & Licensure
- MA State Medical License 2020 - 2025
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 6 citationsAssociation of Interleukin 6 Inhibition With Ziltivekimab and the Neutrophil-Lymphocyte Ratio: A Secondary Analysis of the RESCUE Clinical Trial.Nicholas H Adamstein, Jan Hein Cornel, Michael Davidson, Peter Libby, Alessandra de Remigis, Camilla Jensen, Kathrine Ekström, Paul M Ridker> ;JAMA Cardiology. 2023 Feb 1
- 10 citationsEffect of Secukinumab on Traditional Cardiovascular Risk Factors and Inflammatory Biomarkers: Post Hoc Analyses of Pooled Data Across Three Indications.Iain B McInnes, Atul A Deodhar, Amit K Dey, Nicholas H Adamstein, Erhard Quebe-Fehling, Maher Aassi, Michael Peine, Nehal N Mehta, Merola, J. F., Merola, J. F., Merola...> ;Rheumatology and Therapy. 2022 Jun 1
- 24 citationsInterleukin-1β suppression dampens inflammatory leukocyte production and uptake in atherosclerosis.Jan Hettwer, Julia Hinterdobler, Benedikt Miritsch, Marcus-André Deutsch, Xinghai Li, Carina Mauersberger, Aldo Moggio, Quinte Braster, Hermann Gram, Avril A. B. Rober...> ;Cardiovascular Research. 2021 Oct 28
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: